0

Infectious Disease Collection
 1-20 of 5284 Articles
Ideas and Opinions |  1 September 2015
Regulating Antibiotics in an Era of Resistance: The Historical Basis and Continued Need for Adequate and Well-Controlled InvestigationsRegulating Antibiotics in an Era of Resistance
Scott H. Podolsky, MD; John H. Powers, III, MD
Ann Intern Med. 2015;163(5):386-388. doi:10.7326/M15-0802
Original Research |  25 August 2015 ONLINE FIRST
Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under An Investigational New Drug ProtocolIntravenous Artesunate for Severe Malaria
Patrick S. Twomey, MD; Bryan L. Smith, MD; Cathy McDermott, RN, MPH; et al.
Ann Intern Med. Published online 25 August 2015 doi:10.7326/M15-0910
Ideas and Opinions |  25 August 2015 ONLINE FIRST
Global Noncommunicable Disease Research: Opportunities and ChallengesGlobal NCD Research: Opportunities and Challenges
Lindsay M. Jaacks, PhD; Mohammed K. Ali, MBChB, MSc, MBA; John Bartlett, MD; et al.
Ann Intern Med. Published online 25 August 2015 doi:10.7326/M15-1068
Editorials |  18 August 2015
Celebrating the ACP Centennial: From the Annals Archive—Non-A, Non-B HepatitisCelebrating the ACP Centennial
Deborah Cotton, MD, MPH
Ann Intern Med. 2015;163(4):315. doi:10.7326/M15-1300
Original Research |  18 August 2015
Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System: A Case Series and Chart ReviewUnderascertainment of Acute HCV Infections
Shauna Onofrey, MPH; Jasneet Aneja, MPH; Gillian A. Haney, MPH; et al.
Ann Intern Med. 2015;163(4):254-261. doi:10.7326/M14-2939
Ideas and Opinions |  18 August 2015 FREE
Orchestrated Scientific Collaboration: Critical to the Control of MERS-CoVScientific Collaboration to Control MERS-CoV
Trish M. Perl, MD, MSc; Connie Savor Price, MD
Ann Intern Med. 2015;163(4):313-314. doi:10.7326/M15-1395
Reviews |  11 August 2015 ONLINE FIRST
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysisCorticosteroids for Patients Hospitalized With Community-Acquired Pneumonia
Reed A.C. Siemieniuk, MD; Maureen O. Meade, MD; Pablo Alonso-Coello, MD, PhD; et al.
Ann Intern Med. Published online 11 August 2015 doi:10.7326/M15-0715
Editorials |  11 August 2015 ONLINE FIRST
Corticosteroids for Severe Community-Acquired Pneumonia: Time to Change Clinical PracticeCorticosteroids for Severe Community-Acquired Pneumonia
Marcos I. Restrepo, MD, MSc; Antonio Anzueto, MD; Antoni Torres, MD, PhD
Ann Intern Med. Published online 11 August 2015 doi:10.7326/M15-1805
Reviews |  11 August 2015 FREE ONLINE FIRST
Cleaning Hospital Room Surfaces to Prevent Health Care–Associated Infections: A Technical BriefEnvironmental Cleaning and HAIs
Jennifer H. Han, MD, MSCE*; Nancy Sullivan, BA*; Brian F. Leas, MS, MA*; et al.
Ann Intern Med. Published online 11 August 2015 doi:10.7326/M15-1192
Editorials |  11 August 2015 ONLINE FIRST
Intensifying the Focus on the Contribution of the Inanimate Environment to Health Care–Associated InfectionsContribution of the Inanimate Environment to HAIs
Tara N. Palmore, MD; David K. Henderson, MD
Ann Intern Med. Published online 11 August 2015 doi:10.7326/M15-1798
Ideas and Opinions |  4 August 2015
Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From FictionHCV Treatment and Injection Drug Users
Elinore F. McCance-Katz, MD, PhD; Ronald O. Valdiserri, MD, MPH
Ann Intern Med. 2015;163(3):224-225. doi:10.7326/M15-0007
Medicine and Public Issues |  4 August 2015 FREE
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesMedicaid Restrictions of Sofosbuvir for Hepatitis C
Soumitri Barua; Robert Greenwald, JD; Jason Grebely, PhD; et al.
Ann Intern Med. 2015;163(3):215-223. doi:10.7326/M15-0406
Ideas and Opinions |  4 August 2015
Limited Access to New Hepatitis C Virus Treatment Under State Medicaid ProgramsLimited Access to New HCV Treatment
Lauren A. Canary, MPH; R. Monina Klevens, DDS, MPH; Scott D. Holmberg, MD, MPH
Ann Intern Med. 2015;163(3):226-228. doi:10.7326/M15-0320
Original Research |  4 August 2015 FREE
Active Tracing and Monitoring of Contacts Associated With the First Cluster of Ebola in the United StatesEbola Contact Monitoring in the United States
Wendy M. Chung, MD; Jessica C. Smith, MPH; Lauren M. Weil, PhD, MPH; et al.
Ann Intern Med. 2015;163(3):164-173. doi:10.7326/M15-0968
Original Research |  21 July 2015
Borrelia miyamotoi Disease in the Northeastern United States: A Case SeriesBorrelia miyamotoi Disease in the Northeastern United States
Philip J. Molloy, MD; Sam R. Telford, III, ScD; Hanumara Ram Chowdri, MD; et al.
Ann Intern Med. 2015;163(2):91-98. doi:10.7326/M15-0333
Editorials |  21 July 2015
Borrelia miyamotoi: The Newest Infection Brought to Us by Deer TicksBorrelia miyamotoi
Peter J. Krause, MD; Alan G. Barbour, MD
Ann Intern Med. 2015;163(2):141-142. doi:10.7326/M15-1219
Original Research |  21 July 2015
Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine Among U.S. Women and Girls: A National SurveySexual Orientation Identity and Awareness and Initiation of the HPV Vaccine
Madina Agénor, ScD, MPH; Sarah Peitzmeier, MSPH; Allegra R. Gordon, MPH; et al.
Ann Intern Med. 2015;163(2):99-106. doi:10.7326/M14-2108
Editorials |  21 July 2015
Advancing Care for Lesbian, Gay, Bisexual, and Transgender Persons: Enough Already?Advancing Care for LGBT Persons
Jeanne M. Marrazzo, MD, MPH
Ann Intern Med. 2015;163(2):143-144. doi:10.7326/M15-0329
Reviews |  7 July 2015
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysisOptimal Timing of ART for HIV-Infected Adults With TB
Olalekan A. Uthman, MBBS, MPH, PhD; Charles Okwundu, MBBS, MPH; Kayode Gbenga, MBBS, MPH; et al.
Ann Intern Med. 2015;163(1):32-39. doi:10.7326/M14-2979
Original Research |  7 July 2015
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized TrialC-EDGE Treatment-Naive Trial of Grazoprevir–Elbasvir
Stefan Zeuzem, MD; Reem Ghalib, MD; K. Rajender Reddy, MD; et al.
Ann Intern Med. 2015;163(1):1-13. doi:10.7326/M15-0785
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)